D. Richard Lachno

3.0k citations
41 papers · 1.7k indexed · 1 hit paper · h-index 21
Topics
Alzheimer's disease research and treatments (9 papers)Antiplatelet Therapy and Cardiovascular Diseases (5 papers)Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers)

In The Last Decade

D. Richard Lachno

41 papers receiving 1.7k citations

Hit Papers

Common polymorphisms of CYP2C19 and CYP2C9 affect the pha...20072026201320192007100200300400500

Peers

D. Richard Lachno
Comparison fields: 5 of 111
  • Cardiology and Cardiovascular Medicine 749
  • Surgery 425
  • Molecular Biology 285
  • Physiology 250
  • Pharmacology 223
Replace Tomohiro Osanai with:
Tomohiro Osanai Japan
Kirsten Leineweber Germany
Tsunehiko Kuzuya Japan
W B Campbell United States
Katsuaki Ito Japan
Oleg V. Evgenov United States
Fei Cai China
Yongjun Cao China
Dirk von Lewinski Austria
Alan H. Stephenson United States
D. Richard Lachno relative to Tomohiro Osanai Japan Tomohiro Osanai's profile →
Citations per field
00.5×1.5×1.8×
Tomohiro Osanai · 1×
Citations per year

Countries citing papers authored by D. Richard Lachno

Since Specialization
Citations

This map shows the geographic impact of D. Richard Lachno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Richard Lachno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Richard Lachno more than expected).

Fields of papers citing papers by D. Richard Lachno

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Richard Lachno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Richard Lachno. The network helps show where D. Richard Lachno may publish in the future.

Co-authorship network of co-authors of D. Richard Lachno

This figure shows the co-authorship network connecting the top 25 collaborators of D. Richard Lachno. A scholar is included among the top collaborators of D. Richard Lachno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Richard Lachno. D. Richard Lachno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 54
2 1
3 13
4 28
5 13
6 2
7 39
8 24
9 55
10
Common polymorphisms of CYP2C19 and CYP2C9 affect the pharmacokinetic and pharmacodynamic response to clopidogrel but not prasugrelbreakdown →
553
11 2
12 31
13 30
14 30
15 1
16 2
17 285
18 4
19 15
20 56

About D. Richard Lachno

D. Richard Lachno is a scholar working on Pharmacology, Psychiatry and Mental health and Physiology, having authored 41 papers that have together received 1.7k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (9 papers), Antiplatelet Therapy and Cardiovascular Diseases (5 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers). The work is most often cited by research in Internal Medicine (144 citations), Cardiology and Cardiovascular Medicine (749 citations) and Physiology (96 citations). D. Richard Lachno has collaborated with scholars based in United Kingdom, United States and Belgium. Frequent co-authors include Christopher D. Payne, Kenneth J. Winters, M Yacoub, Ryszard T. Smoleński, S.J.M. Ledingham, Daniel E. Salazar, John T. Brandt, C. Steven Ernest, Nazar Farid and Stephen J. Iturria. Their work appears in journals such as Circulation, Blood and Journal of the American College of Cardiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026